Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07450157) titled 'A Study of Patient Characteristics, Treatment Patterns and Outcomes Among Patients Treated With 177Lu-PSMA-617' on Feb. 27.
Study Type: Observational
Primary Sponsor: Novartis Pharmaceuticals
Condition:
Prostate Cancer
Recruitment Status: Not recruiting
Date of First Enrollment: June 23, 2023
Target Sample Size: 6448
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07450157
Published by HT Digital Content Services with permission from Health Daily Digest....